Delivery Order SPE2DB22D3301-SPE2DB25FY3HS

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,732.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of medical products, specifically "ULTANE 250 ML PEN BOTTLE 250ML", to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,443.90 Firm Fixed Price Delivery Order contract is for the supply of "ULTANE 250 ML PEN BOTTLE 250ML" medical products. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,881.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order for the product "ULTANE 250 ML PEN BOTTLE 250ML" with an ultimate completion date of March 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,887.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs. The contract is for the delivery of 4,567,930,398 units of the medication ULTANE 250 ML PEN...
This federal contract award, valued at $1,395.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567467524 ! ULTANE 250 ML PEN BOTTLE 250ML, a medical product, with a period of performance through March 6, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $1,360.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,926,927 units of ULTANE 250 ML PEN BOTTLE 250ML, a medical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. The contract is not designated as a set-aside and is open to full and open...
This federal contract award, valued at $1,204.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML, a medical product, with a period of performance through November 1, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This is a $1,155.12 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTANE 250 ML PEN BOTTLE 250ML medical products, with a period of performance through April 14, 2025. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.30 Delivery Order contract is for the supply of 4566733376 - ULTANE 250 ML PEN BOTTLE 250ML. The contract is a Firm Fixed Price agreement with a completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML medical supplies to the Defense Logistics Agency (DLA). The contract, valued at $1,437.30, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY3HS
    Delivery Order

This federal contract award, valued at $1,347.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs.

The current delivery order is for the pharmaceutical product "ULTANE 250 ML PEN BOTTLE 250ML", with a performance period through April 2025. As the contract is not designated as a set-aside, it was competed openly. Amerisourcebergen, as the prime contractor, will be responsible for delivering the required pharmaceutical product to support federal agency medical and healthcare needs.

Generated 7/16/25, 11:51 AM